Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ania Skowera

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2010
Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognitionDavid K Cole, Emily S J Edwards, Katherine K Wynn, et al.
The Journal of Clinical Investigation|June 1, 2018
Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetesLorraine Yeo, Alyssa Woodwyk, Sanjana Sood, et al.
Journal of Immunological Methods|October 22, 2008
Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramersAnna Lissina, Kristin Ladell, Ania Skowera, et al.
The Journal of Clinical Investigation|August 16, 2016
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivityDavid K Cole, Anna M Bulek, Garry Dolton, et al.
The Journal of Clinical Investigation|May 17, 2016
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivityDavid K Cole, Anna M Bulek, Garry Dolton, et al.
Diabetes|September 25, 2014
β-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposureAnia Skowera, Kristin Ladell, James E McLaren, et al.
Diabetologia|December 3, 2017
Combinatorial detection of autoreactive CD8<sup>+</sup> T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell WorkshopEddie A James, Joana R F Abreu, John W McGinty, et al.
The Journal of Clinical Investigation|September 20, 2008
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeAnia Skowera, Richard J Ellis, Ruben Varela-Calviño, et al.
Scientific Reports|October 18, 2016
Targeted suppression of autoreactive CD8<sup>+</sup> T-cell activation using blocking anti-CD8 antibodiesMathew Clement, James A Pearson, Stephanie Gras, et al.
Nature Immunology|January 17, 2012
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetesAnna M Bulek, David K Cole, Ania Skowera, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2010
Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognitionDavid K Cole, Emily S J Edwards, Katherine K Wynn, et al.
The Journal of Clinical Investigation|June 1, 2018
Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetesLorraine Yeo, Alyssa Woodwyk, Sanjana Sood, et al.
Journal of Immunological Methods|October 22, 2008
Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramersAnna Lissina, Kristin Ladell, Ania Skowera, et al.
The Journal of Clinical Investigation|August 16, 2016
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivityDavid K Cole, Anna M Bulek, Garry Dolton, et al.
The Journal of Clinical Investigation|May 17, 2016
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivityDavid K Cole, Anna M Bulek, Garry Dolton, et al.
Diabetes|September 25, 2014
β-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposureAnia Skowera, Kristin Ladell, James E McLaren, et al.
Diabetologia|December 3, 2017
Combinatorial detection of autoreactive CD8<sup>+</sup> T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell WorkshopEddie A James, Joana R F Abreu, John W McGinty, et al.
The Journal of Clinical Investigation|September 20, 2008
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeAnia Skowera, Richard J Ellis, Ruben Varela-Calviño, et al.
Scientific Reports|October 18, 2016
Targeted suppression of autoreactive CD8<sup>+</sup> T-cell activation using blocking anti-CD8 antibodiesMathew Clement, James A Pearson, Stephanie Gras, et al.
Nature Immunology|January 17, 2012
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetesAnna M Bulek, David K Cole, Ania Skowera, et al.
Pageof 3